Please login to the form below

Not currently logged in
Email:
Password:

Mundipharma appoints Paul Medeiros head of corporate and business development

He joins from AVI BioPharma and will lead Mundipharma's corporate growth across Europe

Paul Medeiros - MundipharmaAVI BioPharma's Paul Medeiros has joined Mundipharma as head of corporate and business development.

Medeiros will also join the executive leadership team at the UK-based group, which controls Napp in the UK and has associated companies in 32 other European countries.

His role will be to extend and expand areas for growth within this European network of companies.

“Paul's deep experience and network in the pharma industry, combined with his entrepreneurial mind-set and nuanced understanding of the business, will be essential for Mundipharma's continued growth,” said Antony Mattessich, regional director at Mundipharma Europe.

Medeiros was most recently senior VP and chief business officer at AVI BioPharma, a company focused on the development of RNA-based therapeutics for rare diseases.

Other roles in his 19-year career in the biopharma industry include VP, global licensing and strategic alliances for Schering-Plough, as well as several positions in sales and marketing at Merck & Co.

He has been involved with licensing and strategic partnering initiatives in specialist therapy areas, as well as technology acquisitions.

9th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Complete HealthVizion

Complete HealthVizion is a global team of fresh thinkers who aspire to be better every day. We create life-changing medical...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics